Fri.Apr 19, 2024

article thumbnail

GAO Releases Report on States’ Regulation of PBMs

Drug Topics

Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.

233
233
article thumbnail

Gap in Medicaid Impacts Access to Services for Justice-Involved Patients

Pharmacy Times

Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases

148
148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Swipe Right on Wellness: The Rise of Digital Therapeutics in Mental Health

Drug Topics

Digital therapeutics are positioned as front-runners in the increasingly digital future of health care.

220
220
article thumbnail

STAT+: New antibiotics were underprescribed for hard-to-treat infections, study finds

STAT

Although U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year period, hospital doctors instead gave older, generic remedies to more than 40% of patients battling those stubborn pathogens, according to a new analysis. Moreover, 80% of the time these older antibiotics were already known to be highly toxic or ineffective, according to the analysis.

Hospitals 137
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Medicare-Focused Insurance Agency Could Benefit Independent Pharmacies

Drug Topics

A Q&A with Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee.

article thumbnail

Online chatter points to broad layoffs at Optum—but the full extent is unclear

Fierce Healthcare

UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear. | UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear.

137
137

More Trending

article thumbnail

Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC

Pharmacy Times

In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate.

131
131
article thumbnail

Enhancing Patient-Pharmacist Relationships Through Conversation

Drug Topics

Listening carefully to determine what’s beneath the surface of a patient’s concerns can make a world of difference in providing quality care.

123
123
article thumbnail

Study: Chemotherapy to Treat Breast Cancer Increases Risk of Lung Cancer

Pharmacy Times

Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.

article thumbnail

Opinion: Moving the conversation about obesity beyond the scale

STAT

Every so often, the conversations that people in health care have become so pervasive that they dominate the zeitgeist, intersecting with mainstream media and popular culture. Oprah Winfrey’s recent ABC special “Shame, Blame, and the Weight Loss Revolution” is a good example of this. Now streaming on Hulu, the broadcast garnered widespread attention, including coverage from People Magazine and The New York Times.

124
124
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pennsylvania providers file suit against Aetna over breach of contract

Fierce Healthcare

A Pennsylvania provider group has filed suit against Aetna this week, alleging the insurer conducted multiple breaches of contract. | A Pennsylvania provider group has filed suit against Aetna this week, alleging the insurer conducted multiple breaches of contract.

Insurance 120
article thumbnail

STAT+: Medicare official says breakthrough device reimbursement rule coming in early summer

STAT

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday. The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter  in March asking why it has taken so long to get the breakthrough device program moving.

Insurance 124
article thumbnail

FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC

Pharmacy Times

With this approval, alectinib is the first anaplastic lymphoma kinase inhibitor to be approved for patients with ALK-positive, early-stage non-small cell lung cancer.

FDA 118
article thumbnail

Roche snags postsurgery FDA nod for Alecensa, eyes even broader lung cancer use

Fierce Pharma

Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. | Roche isn’t content with Alecensa being the best-selling ALK inhibitor in metastatic lung cancer. The Swiss pharma has now secured an FDA approval in the post-surgical setting as it continues to test the drug in additional patient populations.

FDA 126
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Avive pockets $57M for portable defibrillator to speed up cardiac arrest response

Fierce Healthcare

Portable defibrillator company Avive Solutions raised $56.5 million in growth equity financing to build out its staff and commercial developments. | The company, which launched in 2017, has contracts with four cities for its network of AEDs to improve survival rates of sudden cardiac arrest. It has raised tens of millions to expand operations.

116
116
article thumbnail

Reuters Pharma USA 2024 – Serena Goodwin

pharmaphorum

Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.

113
113
article thumbnail

STAT+: Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape. However, we do foresee several naps in our future, if only to recover from promenading with the official mascots. We also hope to catch up on our reading and hold another listening party with Mrs.

107
107
article thumbnail

LogiPharma Europe 2024: Niklas Adamsson Discusses Ways to Improve Visibility and Risk Management for Cold Chain Shipping

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Environtainer, suggests how to improve visibility and risk management for cold chain shipping.

105
105
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

106
106
article thumbnail

FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease

Pharmacy Times

The primary endpoint of the study was clinical remission at week 52 with vedolizumab

FDA 139
article thumbnail

AI Guided Care Plans Streamline Workflow and Improve Patient Care

Drug Topics

When AI is incorporated into pharmacy workflows, the technology can help pharmacists demonstrate the value of their profession.

article thumbnail

'The Top Line': Winning formulas for the best biotech and drug names

Fierce Pharma

This week on “The Top Line,” we're joined by Fierce Biotech Senior Editor Annalee Armstrong and Fierce Pharma Marketing Senior Editor Ben Adams. | This week on "The Top Line," we are joined by Annalee Armstrong, Senior Editor at Fierce Biotech, and Ben Adams, Senior Editor of Fierce Pharma Marketing, to discuss Fierce's take on March Madness.

105
105
article thumbnail

Farxiga for heart failure: How it works, effectiveness & more

The Checkup by Singlecare

Heart failure is a long-term condition that can affect one or both sides of the heart and occurs when the heart cannot pump enough blood. Symptoms of this serious health condition include shortness of breath, fatigue, coughing, swelling, weight gain, and frequent urination, among others. Heart failure causes fluid buildup as well as decreased blood flow to the organs.

article thumbnail

AskBio’s AB-1002 gene therapy receives FDA fast-track status

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted fast-track designation to Bayer subsidiary Asklepios BioPharmaceutical’s (AskBio) investigational gene therapy AB-1002, aimed at treating congestive heart failure (CHF).

FDA 98
article thumbnail

Vox Pop Pharma - companies keen to find alternatives to animal testing - read their views

Outsourcing Pharma

Earlier this week, Charles River Laboratories International, Inc. revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.

105
105
article thumbnail

Ciprofloxacin for dogs

The Checkup by Singlecare

Ciprofloxacin is a broad-spectrum antibiotic that veterinarians may use off-label in dogs. Ciprofloxacin is a fluoroquinolone antibiotic. It kills bacteria by damaging the bacteria’s DNA without affecting the DNA in animals or humans. Although it’s very effective at killing bacteria, it does have problems in dogs that may make other antibiotics a better choice.

Dosage 97
article thumbnail

Behind the ‘encouraging’ new results for Amylyx’s beleaguered drug

PharmaVoice

Where Amylyx ultimately failed in ALS, it could prevail in a rare disease. The doctor leading this research explains why.

119
119
article thumbnail

FDA clears Roche’s Alecensa for adjuvant use in NSCLC

pharmaphorum

Roche's Alecenesa has become the first ALK inhibitor to be approved by the FDA for adjuvant use in early-stage, ALK+ NSCLC

FDA 114
article thumbnail

FibroGen settles with former employees who it claimed stole trade secrets

Fierce Pharma

Nearly a year and a half after FibroGen slapped a pair of former employees with a lawsuit alleging trade secrets theft, both the plaintiffs and the defendants are walking away from the case little | Nearly a year and a half after FibroGen slapped a pair of former employees with a lawsuit alleging trade secrets theft, both the plaintiffs and the defendants are walking away from the case little worse for wear.

104
104
article thumbnail

Cerevel Parkinson’s data adds lustre to AbbVie acquisition

pharmaphorum

Cerevel's first phase 3 trial of Parkinson's drug tavapadon is positive - good news for AbbVie which is trying to buy the biotech for $8.

105
105
article thumbnail

Chutes & Ladders—Sutter Health appoints first CMO; More change at Banner Health

Fierce Healthcare

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry.

116
116
article thumbnail

Hyundai Bio plans trials of antiviral for dengue fever

pharmaphorum

Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever

110
110
article thumbnail

Q&A: Cell and gene therapy value assessments need a rework to allow access

Pharmaceutical Technology

Paolo Morgese, vice president of European public affairs at the Alliance for Regenerative Medicine, discusses the barriers affecting access to gene therapies.

95
article thumbnail

Experimental AI predicts whether cancer drugs will work

pharmaphorum

Researchers in the US have developed an artificial intelligence tool that can predict how a patient will respond to cancer treatment

105
105